The landscape of reported VUS in multi-gene panel and genomic testing: Time for a change-Reference-Cited by-同舟云学术

The landscape of reported VUS in multi-gene panel and genomic testing: Time for a change

Published:2023-12 Issue:12 Volume:25 Page:100947
ISSN:1098-3600
Container-title:Genetics in Medicine
language:en
Short-container-title:Genetics in Medicine

Author:

Rehm Heidi L.^ORCID,Alaimo Joseph T.,Aradhya Swaroop,Bayrak-Toydemir Pinar,Best Hunter,Brandon Rhonda,Buchan Jillian G.,Chao Elizabeth C.,Chen Elaine,Clifford Jacob,Cohen Ana S.A.,Conlin Laura K.,Das Soma,Davis Kyle W.,del Gaudio Daniela,Del Viso Florencia,DiVincenzo Christina,Eisenberg Marcia,Guidugli Lucia,Hammer Monia B.,Harrison Steven M.,Hatchell Kathryn E.,Dyer Lindsay Havens,Hoang Lily U.,Holt James M.,Jobanputra Vaidehi,Karbassi Izabela D.,Kearney Hutton M.,Kelly Melissa A.,Kelly Jacob M.,Kluge Michelle L.,Komala Timothy,Kruszka Paul,Lau Lynette,Lebo Matthew S.,Marshall Christian R.,McKnight Dianalee,McWalter Kirsty,Meng Yan,Nagan Narasimhan,Neckelmann Christian S.,Neerman Nir,Niu Zhiyv,Paolillo Vitoria K.,Paolucci Sarah A.,Perry Denise,Pesaran Tina,Radtke Kelly,Rasmussen Kristen J.,Retterer Kyle,Saunders Carol J.,Spiteri Elizabeth,Stanley Christine,Szuto Anna,Taft Ryan J.,Thiffault Isabelle,Thomas Brittany C.,Thomas-Wilson Amanda,Thorpe Erin,Tidwell Timothy J.,Towne Meghan C.,Zouk Hana,Marshall Christian,Meng Linyan,Jobanputra Vaidehi,Taft Ryan,Ashley Euan,Nakouzi Ghunwa,Shen Wei,Kingsmore Stephen,Rehm Heidi

Funder

National Human Genome Research Institute

Publisher

Elsevier BV

Subject

Genetics (clinical)

Reference12 articles.

1. Experiences of individuals with a variant of uncertain significance on genetic testing for hereditary cancer risks: a mixed method systematic review;Gould;J Community Genet,2022

2. Variant interpretation using population databases: lessons from gnomAD;Gudmundsson;Hum Mutat,2022

3. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology;Richards;Genet Med,2015

4. A standardized DNA variant scoring system for pathogenicity assessments in Mendelian disorders;Karbassi;Hum Mutat,2016

5. Reanalysis of eMERGE phase III sequence variants in 10,500 participants and infrastructure to support the automated return of knowledge updates;Zouk;Genet Med,2022

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fetal whole genome sequencing as a clinical diagnostic tool: Advantages, limitations and pitfalls;Best Practice & Research Clinical Obstetrics & Gynaecology;2024-12

2. Germline variant profiling of CHEK2 sequencing variants in breast cancer patients;Cancer Genetics;2024-11

3. Germline genetic testing reveals pathogenic variants in uterine serous carcinoma patients;Gynecologic Oncology Reports;2024-10

4. Prevention, diagnosis and clinical management of hereditary breast cancer beyond BRCA1/2 genes;Cancer Treatment Reviews;2024-09

5. Clinical validation of RNA sequencing for Mendelian disorder diagnostics;2024-08-17